Accessibility Menu
 
ImpediMed logo

ImpediMed

(ASX) IPD

Current Price$0.01
Market Cap$28.54M
Since IPO (2007)-98%
5 Year-88%
1 Year-67%
1 Month-7%

ImpediMed Financials at a Glance

Market Cap

$28.54M

Revenue (TTM)

$25.77M

Net Income (TTM)

$45.59M

EPS (TTM)

$-0.01

P/E Ratio

-1.17

Dividend

$0.00

Beta (Volatility)

0.07 (Low)

Price

$0.01

Volume

0

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.06

IPD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ImpediMed

Industry

Healthcare Equipment and Supplies

Employees

77

CEO

Parmjot Bains, PhD

Headquarters

Pinkenba, QLD 4008, AU

IPD Financials

Key Financial Metrics (TTM)

Gross Margin

-6%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-118%

Return on Capital

-71%

Return on Assets

-64%

Earnings Yield

-85.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$28.54M

Shares Outstanding

2.04B

Volume

0

Avg. Volume

5.10M

Financials (TTM)

Gross Profit

$10.97M

Operating Income

$24.23M

EBITDA

$17.55M

Operating Cash Flow

$14.64M

Capital Expenditure

$989.00K

Free Cash Flow

$15.63M

Cash & ST Invst.

$22.18M

Total Debt

$14.49M

ImpediMed Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$7.52M

+57.1%

Gross Profit

$6.52M

+16.8%

Gross Margin

-86.70%

N/A

Market Cap

$28.54M

N/A

Market Cap/Employee

$343.89K

N/A

Employees

83

N/A

Net Income

$12.28M

-26.4%

EBITDA

$7.51M

+16.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$3.09M

-108.7%

Accounts Receivable

$3.76M

+41.1%

Inventory

$2.27M

+152.2%

Long Term Debt

$21.63M

+2146.2%

Short Term Debt

$303.00K

-2.3%

Return on Assets

-63.53%

N/A

Return on Invested Capital

-70.68%

N/A

Free Cash Flow

$0.00

+100.0%

Operating Cash Flow

$9.50M

-40.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PCK.AXPainChek Limited
$0.14-9.38%
EYE.AXNova Eye Medical Limited
$0.13-3.85%
GSS.AXGenetic Signatures Limited
$0.09+7.32%
MX1.AXMicro-X Limited
$0.05+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$50.22-0.03%

Questions About IPD

What is the current price of ImpediMed?

ImpediMed is trading at A$0.01 per share.

What is the 52-week range for ImpediMed?

Over the past 52 weeks, ImpediMed has traded between A$0.01 and A$0.06.

How much debt does ImpediMed have?

As of the most recent reporting period, ImpediMed reported total debt of $14.49M.

How much cash does ImpediMed have on hand?

ImpediMed reported $22.18M in cash and cash equivalents in its most recent financial results.

What is ImpediMed’s dividend yield?

ImpediMed does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.